056 622 42 50

Common Myths and Facts About Liquid Viagra

Viagra > liquid viagra


The erectile response, as assessed by RigiScan®, generally

Adverse effects

No dose adjustment is required for mild (CLcr=50-80 mL/min) and moderate (CLcr=30-49 mL/min) renal impairment. In volunteers with severe renal impairment (Clcr < 30 mL/min), sildenafil clearance was reduced, resulting in higher plasma exposure of sildenafil (~2 fold), approximately doubling of Cmax and AUC. A starting dose of 25 mg should be considered in patients with severe renal impairment [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. In volunteers with hepatic impairment (Child-Pugh Class A and B), sildenafil clearance was reduced, resulting in higher plasma exposure of sildenafil (47% for C max and 85% for AUC). The pharmacokinetics of sildenafil in patients with severely impaired hepatic function (Child-Pugh Class C) have not been studied.

How it works

A starting dose of 25 mg should be considered in patients with any degree of hepatic impairment [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. In studies with healthy volunteers of single doses up to 800 mg, adverse reactions were similar to those seen at lower doses but incidence rates and severities were increased. In cases of overdose, standard supportive measures should be adopted as required. Renal dialysis is not expected to accelerate clearance as sildenafil is highly bound to plasma proteins and it is not eliminated in the urine. Consistent with its known effects on the nitric oxide/cGMP pathway [see CLINICAL PHARMACOLOGY], VIAGRA was shown to potentiate the hypotensive effects of nitrates, and its administration to patients who are using nitric oxide donors such as organic nitrates or organic nitrites in any form either regularly and/or intermittently is therefore contraindicated.

How sildenafil is used

After patients have taken VIAGRA, it is unknown when nitrates, if necessary, can be safely administered. Although plasma levels of sildenafil at 24 hours post dose are much lower than at peak concentration, it is unknown whether nitrates can be safely coadministered at this time point [see DOSAGE AND ADMINISTRATION, DRUG INTERACTIONS, and CLINICAL PHARMACOLOGY]. VIAGRA is contraindicated in patients with a known hypersensitivity to sildenafil, as contained in VIAGRA and REVATIO, or any component of the tablet. Hypersensitivity reactions have been reported, including rash and urticaria [see ADVERSE REACTIONS]. Do not use VIAGRA in patients who are using a GC stimulator, such as riociguat. increased with increasing sildenafil

Product Dosage Quantity + Bonus Price
Viagra Generic25mg120 + 6 Pills125.56€ 119.58€
Viagra Soft Tabs100mg10 Pills36.93€ 35.17€
Viagra Original100mg48 + 4 Pills207.15€ 197.29€
Viagra Super Active100mg360 + 30 Pills470.93€ 448.50€
Viagra Original100mg4 Pills40.94€ 38.99€
Viagra Oral Jelly100mg110 + 9 Sachets284.63€ 271.08€
Viagra Generic50mg20 Pills40.52€ 38.59€
Viagra Generic25mg10 Pills25.19€ 23.99€
Viagra Generic25mg180 + 6 Pills154.93€ 147.55€
Viagra Generic25mg60 + 4 Pills71.99€ 68.56€
Viagra Generic100mg10 Pills28.91€ 27.53€
Viagra Professional100mg60 + 2 Pills146.74€ 139.75€
Viagra Generic150mg20 Pills55.02€ 52.40€
Viagra Generic50mg360 + 10 Pills225.33€ 214.60€
Viagra Original100mg76 + 4 Pills306.59€ 291.99€
Viagra Oral Jelly100mg21 Sachets78.66€ 74.91€
Viagra Professional100mg30 Pills88.92€ 84.69€

dose and plasma concentration.

What happens if I overdose?

There was no impairment of fertility in rats given sildenafil up to 60 mg/kg/day for 36 days to females and 102 days to males, a dose producing an AUC value of more than 25 times the human male AUC. VIAGRA is not indicated for use in women. There are no adequate and well-controlled studies of sildenafil in pregnant women. Based on animal data, VIAGRA is not predicted to increase the risk of adverse developmental outcomes in humans. No evidence of teratogenicity, embryotoxicity or fetotoxicity was observed in rats and rabbits which received up to 200 mg/kg/day during organogenesis.

Does Viagra help with premature ejaculation?

These doses represent, respectively, about 20 and 40 times the Maximum Recommended Human Dose (MRHD) on a mg/m² basis in a 50 kg subject. In the rat pre-and postnatal development study, the no observed adverse effect dose was 30 mg/kg/day given for 36 days. In the nonpregnant rat the AUC at this dose was about 20 times human AUC. VIAGRA is not indicated for use in pediatric patients. Safety and effectiveness have not been established in pediatric patients.

Revatio Tablets

Healthy elderly volunteers (65 years or over) had a reduced clearance of sildenafil resulting in approximately 84% and 107% higher plasma AUC values of sildenafil and its active N-desmethyl metabolite, respectively, compared to those seen in healthy young volunteers (18-45 years) [see CLINICAL PHARMACOLOGY]. Due to age-differences in plasma protein binding, the corresponding increase in the AUC of free (unbound) sildenafil and its active N-desmethyl metabolite were 45% and 57%, respectively [see CLINICAL PHARMACOLOGY]. Of the total number of subjects in clinical studies of Viagra, 18% were 65 years and viagra connect form older, while 2% were 75 years and older. No overall differences in safety or efficacy were observed between older ( > 65 years of age) and younger ( < 65 years of age) subjects. However, since higher plasma levels may increase the incidence of adverse reactions, a starting dose of 25 mg should be considered in older subjects due to the higher systemic exposure [see DOSAGE AND ADMINISTRATION]. The time course of effect was

Side Effect Frequency (%) Severity Notes
Headache 15 Mild Usually resolves in hours
Flushing 10 Mild Temporary redness
Nasal Congestion 8 Mild When using spray-based versions
Dizziness 5 Moderate Stop medication if persistent

examined in one study, showing an effect

Parameter Value Notes
Absorption Time 15-30 minutes Depends on administration
Peak Plasma Concentration 60 minutes After ingestion
Half-life 4 hours Clearance from body
Bioavailability 40-45% Oral liquid form

for up to 4 hours but the

What special dietary instructions should I follow?

Physicians should advise patients to stop use of all PDE5 inhibitors, including VIAGRA, and seek medical attention in the event of a sudden loss of vision in one or both eyes. Such an event may be a sign of non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including possible permanent loss of vision, that has been reported rarely post-marketing in temporal association with the use of all PDE5 inhibitors. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors. Physicians should discuss with patients the increased risk of NAION in individuals who have already experienced NAION in one eye. Physicians should also discuss with patients the increased risk of NAION among the general population in patients with a “crowded” optic disc, although evidence is insufficient to support screening of prospective users of PDE5 inhibitor, including VIAGRA, for this uncommon condition [see WARNINGS AND PRECAUTIONS and ADVERSE REACTIONS].

When to call your doctor

It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors [see WARNINGS AND PRECAUTIONS and ADVERSE REACTIONS]. Physicians should warn patients that prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in duration) have been reported infrequently since market approval of VIAGRA. If priapism is not treated immediately, penile tissue damage and permanent loss of potency may result [see WARNINGS AND PRECAUTIONS]. Physicians should inform patients not to take VIAGRA with other PDE5 inhibitors including REVATIO or other pulmonary arterial hypertension (PAH) treatments containing sildenafil. Sildenafil is also marketed as REVATIO for the treatment of PAH.

How to relieve Viagra side effects

The safety and efficacy of VIAGRA with other PDE5 inhibitors, including REVATIO, have not been studied [see WARNINGS AND PRECAUTIONS]. Counseling of patients about the protective measures necessary to guard against sexually transmitted diseases, including the Human Immunodeficiency Virus (HIV), may be considered [see WARNINGS AND PRECAUTIONS]. Sildenafil was not carcinogenic when administered to rats for 24 months at a dose resulting in total systemic drug exposure (AUCs) for unbound sildenafil and its major metabolite of 29-and 42-times, for male and female rats, respectively, the exposures observed in human males given the Maximum Recommended Human Dose (MRHD) of 100 mg. Sildenafil was not carcinogenic when administered to mice for 18-21 months at dosages up to the Maximum Tolerated Dose (MTD) of 10 mg/kg/day, approximately 0.6 times the MRHD on a mg/m² basis. Sildenafil was negative in in vitro bacterial and Chinese hamster ovary cell assays to detect mutagenicity, and in vitro human lymphocytes and in vivo mouse micronucleus assays to detect clastogenicity. response was diminished compared to 2 hours.

Form Cost per Dose (USD) Ease of Use Notes
Liquid Viagra (per 10 ml) $2.50 High Rapid absorption, customizable doses
Tablets (50 mg) $1.00 Moderate Requires water, standardized dose
Generic Pills $0.80 Moderate Less convenient, lower dosing flexibility

Single oral doses of sildenafil (100

mg) administered to healthy volunteers produced decreases

in sitting blood pressure (mean maximum decrease in systolic/diastolic blood pressure of 8.3/5.3 mmHg).

Report Problems to the Food and Drug Administration

PDE5 inhibitors, including VIAGRA, may potentiate the hypotensive effects of GC stimulators. The physiologic mechanism of erection of the penis involves release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation. NO then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood. When sexual stimulation causes local release of NO, inhibition of PDE5 by sildenafil causes increased levels of cGMP in the corpus cavernosum, resulting in smooth muscle relaxation and inflow of blood to the corpus cavernosum. Sildenafil at recommended doses has no effect in the absence of sexual stimulation.

Sudden vision loss

Studies in vitro have shown that sildenafil is selective for PDE5. Its effect is more potent on PDE5 than on other known phosphodiesterases (10-fold for PDE6, >80-fold for PDE1, >700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). Sildenafil is approximately 4,000-fold more selective for PDE5 compared to PDE3. PDE3 is involved in control of cardiac contractility. Sildenafil is only about 10-fold as potent for PDE5 compared to PDE6, an enzyme found in the retina which is involved in the phototransduction pathway of the retina.

Effectiveness and safety

This lower selectivity is thought to be the basis for abnormalities related to color vision [see Pharmacodynamics]. In addition to human corpus cavernosum smooth muscle, PDE5 is also found in other tissues including platelets, vascular and visceral smooth muscle, and skeletal muscle, brain, heart, liver, kidney, lung, pancreas, prostate, bladder, testis, and seminal vesicle. The inhibition of PDE5 in some of these tissues by sildenafil may be the basis for the enhanced platelet antiaggregatory activity of NO observed in vitro, an inhibition of platelet thrombus formation in vivo and peripheral arterial-venous dilatation in vivo. In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (RigiScan®), after VIAGRA administration compared with placebo. Most studies assessed the efficacy of VIAGRA approximately 60 minutes post dose.

Physiotherapie

Manuelle Therapie, Gelenkmanipulation, Stosswellen-Therapie, Rückenturnen, Sport-Physiotherapie, Golf-Physiotherapie, Stabilität, Kiefergelenksbehandlungen, MTT ...


mehr zur Physiotherapie

Erfahrung

Unser Team mit Dipl. Physiotherapeuten hat sich kontinuierlich weitergebildet und methodisch und technologisch gerüstet. Seit über 30 Jahren helfen wir unseren Patienten die Lebensqualität zu verbessern.


mehr zu unserem Team

Kundenbewertung

Bewertungen zu physio-humbel.ch

1F7A0790
1F7A0795
1F7A0805
1F7A0825
1F7A0837
1F7A0847
1F7A0856
1F7A0865
1F7A0868
1F7A0872

Die Praxis kann wieder direkt angefahren werden.
Keine Umleitung mehr.